We See Things Differently
STRATEGIC INTERDISCIPLINARY COUNSELING
We see solutions through a different lens. Our diverse group of experienced attorneys understands our clients’ business objectives. For decades, our attorneys have served a broad spectrum of clients spanning the globe in the technology and life sciences industries.
Anti-Counterfeiting
Our team works closely with our clients to develop innovative enforcement strategies and measures to manage complex international counterfeiting problems. We manage enforcement operations across multiple marketplaces, jurisdictions, and platforms to help prevent market proliferation. By putting brand protection first, Haug Partners applies successful anti-counterfeiting strategies to stay ahead of counterfeiters.
Antitrust Litigation
& Counseling
Our attorneys have government and private practice experience in a wide variety of antitrust matters, allowing us to provide our clients with a clear understanding of how the antitrust laws and business realities intersect. Haug Partners has the expertise, experience, and resources to handle any civil antitrust and competition issues that arise in the context of settlements, private class action lawsuits, mergers and acquisitions, and civil enforcement actions.
Commercial Litigation
& Strategic Counseling
With our team’s wide-ranging scientific and commercial knowledge, and litigation and arbitration experience, Haug Partners helps clients navigate through the array of relationships that are vital to their business. Haug Partners attorneys anticipate issues and counsel clients to tailor contracts and manage key relationships to avoid disputes. Not every matter requires resolution in the courtroom, and when disputes arise we help clients attempt to resolve them through negotiations or mediations. But when appropriate, we are ready to litigate complex, high-stakes cases of strategic importance to our clients.
Due Diligence
Our attorneys have conducted due diligence relating to the sale, acquisition, and licensing of assets in a wide variety of fields. Consistent with the Haug Partners philosophy, we follow a holistic approach to due diligence, which integrates multiple legal and technical disciplines. We take pride in immersing ourselves in the relevant technology to identify critical issues. We have the resources and experience to timely deliver on the most urgent and time-sensitive projects.
FDA Compliance
& Counseling
Our attorneys’ government experience, and Agency/industry contacts, coupled with Haug Partners’ technical and legal expertise allows us to provide unparalleled regulatory representation and counseling. For decades, our attorneys have helped shepherd our life science and medical device clients through complex regulations and administrative procedures in all manner of Agency proceedings.
Intellectual Property
Enforcement
Haug Partners has attorneys and advisors who hold advanced degrees in specialized technical fields, and extensive experience in diverse industries. Our litigators draw on this expertise to explain complex technical and legal concepts to lay judges and juries. Haug Partners routinely appears before federal district courts, the Patent Trial and Appeal Board, and the Court of Appeals for the Federal Circuit in cases that covers all areas of intellectual property, including patents, trademarks, copyrights, trade secrets, business torts, and contractual disputes.
Intellectual Property
Procurement & Strategy
We collaborate with our clients to provide comprehensive legal strategies from the inception of an idea through commercialization and next-generation planning. Industry leaders trust and rely on Haug Partners to help them procure, manage, protect, and maximize the lifecycles of their most valuable intellectual property assets.
International Trade Commission
Companies may need to seek or protect against exclusion orders that bar imports of products. ITC proceedings are fast-moving, complex, and require the advice and guidance of experienced counsel. Haug Partners has the experience and resources to achieve optimal outcomes under the ITC’s unique procedures and tight deadlines.
Investigations,
Compliance,
& Risk Mitigation Services
Internal investigations and compliance reviews are among the most critical steps companies can take to identify and mitigate risk. Haug Partners attorneys help clients pinpoint their weaknesses and build and implement ethical practices to address potential vulnerabilities. If civil claims arise, our attorneys will find ways to minimize exposure.
Licensing
& Transactions
Haug Partners understands the technical subject matter and the intellectual property and antitrust law ramifications at the heart of our clients’ deals. We blend these skills with our understanding of our clients’ business objectives to draft and negotiate the terms necessary to get deals done while ensuring that they realize their expected value. Our advice does not stop with the consummation of a deal; we continue to advise our clients throughout the course of their business dealings, helping them understand their obligations and rights throughout a transaction’s lifecycle.
PTAB Post-Grant Review
Our PTAB team includes attorneys and technical advisors with substantial scientific and legal skills. We represent large, well-known businesses in critical IPRs and consistently have achieved exceptional results for our clients. Our mastery of patent law, science, and nuanced PTAB procedures yields critical insights when litigating complex patent cases. This approach has been key to our effective representation of innovative pharmaceutical, biotechnology, automotive, biomedical device, computer science and software, and mechanical and electrical device clients at the PTAB.
Trademark
& Unfair Competition
Haug Partners’ Trademark and Unfair Competition practice focuses on all aspects of global brand management, including trademark strategy, procurement, and enforcement. Our attorneys have a wide breadth of experience in trademark, trade dress, copyright, unfair competition, online and social media infringement, and other intellectual property matters. We rely upon this experience to achieve exceptional results for our clients while actively managing global trademark and intellectual property portfolios and enforcing our clients’ intellectual property rights in proceedings around the world.
STRATEGIC INTERDISCIPLINARY COUNSELING
We see solutions through a different lens. Our diverse group of experienced attorneys understands our clients’ business objectives. For decades, our attorneys have served a broad spectrum of clients spanning the globe in the technology and life sciences industries.
Intelligence
View all
- USPTO Issues Revised Guidelines Regarding Trademark Rule Changes—Owner E-mail Requirement Changed
-
Overview of the USPTO's Audit Program and Proposed Fee Increases in 2020
梗概：美国专利商标局商标审查程序以及正在提议的2020年费用提高 -
USPTO Issues Guidelines Regarding February 15, 2020, Trademark Rule Changes
USPTO下发了关于即将在2020年二月十五日生效的行政规定修改的指导意见 - FDA And FTC To Scrutinize Biologics Competition
Selected Clients & Testimonials
Offices
Conveniently located in Midtown Manhattan, Haug Partners’ New York headquarters occupies three floors of the historic Plaza District building on Fifth Avenue.
Our New York office is home to our state-of-the-art litigation suite, which features a fully functioning mock courtroom, war rooms, conference space, witness-preparation rooms, and document/duplication services.
Haug Partners’ Washington, DC office offers quick access to the Court of Appeals for the Federal Circuit; the U.S. Patent and Trademark Office; the U.S. International Trade Commission; the Department of Justice; the Federal Trade Commission; the Food and Drug Administration; and federal district courts in the District of Columbia, Maryland, and Virginia.
With spectacular views of Boston Harbor, Haug Partners’ Boston office is located at One Post Office Square, and is within walking distance to South Station, the Seaport, Boston’s courthouses, and the Red Line to Cambridge. Haug Partners’ Boston team is focused on providing the full-range of our services to Boston’s biopharma and technology companies.